Most cited papers from Asklepios Kliniken Hamburg

The most cited paper from Asklepios Kliniken Hamburg is "Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial" (Severine A.R.A. Vermeire, Stefan Schreiber, Robert Petryka et al., 2016), with 441 citations. Next come "Genome-wide meta-analyses of nonsyndromic cleft lip with or without cleft palate identify six new risk loci" (364) and "Open-label, multicentre, dose-escalating phase II clinical trial on the safety and efficacy of tadekinig alfa (IL-18BP) in adult-onset Still's disease" (296).

Showing 50 of 59 papers. Every paper with more than 61 citations is listed.

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.